SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $97,000 | -33.1% | 14,515 | 0.0% | 0.01% | -45.5% |
Q3 2021 | $145,000 | -78.4% | 14,515 | -33.2% | 0.01% | -82.5% |
Q2 2021 | $672,000 | -29.2% | 21,740 | 0.0% | 0.06% | -25.0% |
Q1 2021 | $949,000 | -5.8% | 21,740 | 0.0% | 0.08% | +18.3% |
Q4 2020 | $1,007,000 | – | 21,740 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |